{"schema_version":"secwatch.filing_event.v1","accession":"0001299130-26-000012","form_type":"8-K","ticker":"PACB","cik":"0001299130","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","filed_at":"2026-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.744842+00:00","generated_at":"2026-05-16T05:16:20.929430+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Pacific Biosciences CEO and COO swap interim responsibilities effective Jan 28, 2026","bullets":["CEO Christian Henry assumes interim oversight of operations and R&D from COO Mark Van Oene.","COO Mark Van Oene assumes interim oversight of sales and customer support from CEO Christian Henry.","No changes to titles or compensation for either executive as a result of the reassignment.","Effective date of role adjustment: January 28, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001299130-26-000012","json":"https://secwatch.observer/filing/0001299130-26-000012.json","markdown":"https://secwatch.observer/filing/0001299130-26-000012.md","text":"https://secwatch.observer/filing/0001299130-26-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000012/0001299130-26-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000012/pacb-20260128.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:16:20.929430+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}